Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Derived from musculoskeletal system – other than cardiac muscle
Patent
1990-07-10
1993-09-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Derived from musculoskeletal system, other than cardiac muscle
530350, 530841, 514356, C01C 1244, A61K 3144, A61K 300
Patent
active
052426920
ABSTRACT:
A factor isolable from muscle tissue or muscle cell culture inhibits proliferation of tumor cells, such as ESB, HT-29 and B-16 F1 cell lines, as well as the peripheral white blood cells of a patient with chronic myeloid leukemia. The active fraction has a molecular weight in the range of 25-30,000 daltons.
REFERENCES:
patent: Re30239 (1980-03-01), Kuettner et al.
patent: 4042457 (1977-08-01), Kuettner et al.
patent: 4356261 (1982-10-01), Kuettner
patent: 4690935 (1987-09-01), Taylor et al.
patent: 4822607 (1989-04-01), Balassa et al.
patent: 4950680 (1990-08-01), Taylor et al.
Schirmacher V., Tumor Metastases and Cell-Mediated Immunity in a Model System in DBA/2 Mice. V. Transfer of Protective Immunity with H-2 Identical Immune T cells from B10.D2 Mice, Int. J. Cancer, 1979, 233-234.
Nichols, W. W. et al., Characterization of a new Human Diploid Cell Strain, IMR-90., Science, 1977, 196, 60-63.
Djaldetti Meir
Fishman Pnina
Sredni Benjamin
Bar Ilan University
Robinson Douglas W.
Ware Deborah K.
LandOfFree
Anti-metastatic factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-metastatic factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-metastatic factor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-486048